Effect of acute and subchronic subcutaneous urocortin on blood pressure and food consumption in ob/ob mice

被引:14
作者
Cohen, ML [1 ]
Bloomquist, W [1 ]
Li, D [1 ]
Iyengar, S [1 ]
机构
[1] Eli Lilly & Co, Lilly Corp Ctr, Lilly Res Labs, Indianapolis, IN 46285 USA
来源
GENERAL PHARMACOLOGY-THE VASCULAR SYSTEM | 2000年 / 34卷 / 06期
关键词
subcutaneous; urocortin - acute and chronic; hypotension; ob/ob mice; food consumption; appetite suppression; blood pressure;
D O I
10.1016/S0306-3623(00)00077-X
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Corticotropin-releasing factor and urocortin belong to a hypothalamic peptide family thought to be important in appetite regulation. The present study compared the appetite-suppressant effect of subcutaneous urocortin in obese mice to its cardiovascular effects. Acutely, urocortin (100 nmol/kg iv) reduced blood pressure and increased heart rate in urethane anesthetized nonobese mice; effects similar to those produced by subcutaneous urocortin (10 and 100 nmol/kg sc) in nonobese and ob/ob mice. Over this same dose range (10-100 nmol/kg sc), urocortin dramatically inhibited food consumption in the ob/ob mouse. To determine if the acute hypotensive effect of urocortin (10 nmol/kg sc) in the ob/ob mouse persisted after repeated urocortin administration, animals were pretreated for 3 days with urocortin (10 nmol/kg sc) or vehicle. Following urocortin pretreatment. urocortin-induced hypotension was similar to the effect in vehicle pretreated mice. However, urocortin-induced appetite suppression was reduced following 3 days of pretreatment with urocortin (10 nmol/kg sc) to ob/ob mice. These data suggest that the hypotensive and appetite-suppressant effects of urocortin are mediated by different mechanisms and tolerance to the hypotension did not readily occur in obese animals. (C) 2001 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:371 / 377
页数:7
相关论文
共 17 条
[1]   Pharmacokinetics, cortisol release, and hemodynamics after intravenous and subcutaneous injection of human corticotropin-releasing factor in humans [J].
Angst, MS ;
Dyck, JB ;
Azarnoff, DL ;
Goldblum, R ;
Ho, B ;
Gfroerer, T ;
Linton, EA ;
Glynn, BP ;
Shafer, SL .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1998, 64 (05) :499-510
[2]   Urocrotin reduces food intake and gastric emptying in lean and ob/ob obese mice [J].
Asakawa, A ;
Inui, A ;
Ueno, N ;
Makino, S ;
Fujino, MA ;
Kasuga, W .
GASTROENTEROLOGY, 1999, 116 (06) :1287-1292
[3]  
Behan DP, 1996, MOL PSYCHIATR, V1, P265
[4]   CENTRAL NERVOUS-SYSTEM EFFECTS OF CORTICOTROPIN RELEASING-FACTOR IN THE DOG [J].
BROWN, MR ;
FISHER, LA .
BRAIN RESEARCH, 1983, 280 (01) :75-79
[5]   Effect of the antiobesity agent sibutramine in obese-diabetic ob/ob mice [J].
Day, C ;
Bailey, CJ .
INTERNATIONAL JOURNAL OF OBESITY, 1998, 22 (07) :619-623
[6]   CORTICOTROPIN-RELEASING FACTOR (CRF) - CENTRAL EFFECTS ON MEAN ARTERIAL-PRESSURE AND HEART-RATE IN RATS [J].
FISHER, LA ;
RIVIER, J ;
RIVIER, C ;
SPIESS, J ;
VALE, W ;
BROWN, MR .
ENDOCRINOLOGY, 1982, 110 (06) :2222-2224
[7]   CORTICOTROPIN-RELEASING FACTOR (CRF) - MECHANISM TO ELEVATE MEAN ARTERIAL-PRESSURE AND HEART-RATE [J].
FISHER, LA ;
JESSEN, G ;
BROWN, MR .
REGULATORY PEPTIDES, 1983, 5 (02) :153-161
[8]   Effects of leptin on corticotropin-releasing factor (CRF) synthesis and CRF neuron activation in the paraventricular hypothalamic nucleus of obese (ob/ob) mice [J].
Huang, QL ;
Rivest, R ;
Richard, D .
ENDOCRINOLOGY, 1998, 139 (04) :1524-1532
[9]  
Jain V, 1999, J PHARMACOL EXP THER, V288, P407
[10]   Vasodilator actions of urocortin and related peptides in the human perfused placenta in vitro [J].
Leitch, IM ;
Boura, ALA ;
Botti, C ;
Read, MA ;
Walters, WAW ;
Smith, R .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (12) :4510-4513